Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 June 2019 | Story Ruan Bruwer
Louzanne Coetzee
Athlete Louzanne Coetzee with the trophy of the Free State Sports Association for the Physically Disabled as Sports Star of the Year.

Although challenging, very exciting and a new journey, says Louzanne Coetzee about the athletics year for which she has been recognised.

The 26-year-old, who is doing her master’s in Social Cohesion and Reconciliation Studies at the University of the Free State, won the Free State Sports Association for the Physically Disabled (FSSAPD) Sports Star of the Year award for a fourth consecutive time. This was for the period June 2018 to April 2019.

In that time, she set a world record, an Africa record, and ran two marathons in which she came amazingly close to a second world record.

Only in her second marathon at the Berlin Marathon in September, the Paralympian fell 26 seconds short of the T11 (totally blind) world record time. She met the qualifying time for the 2020 Paralympic Games in Tokyo during the London Marathon in April.

“Marathons are definitely challenging and a new field for me, but I would say it has been a good 12 months. My aim is now set on next year’s Paralympic Games, where I would like to compete in the marathon and the 1 500 m.”

“I hope to run a good time in the 1 500 m at the World Para Athletics Championships in November.”

At the SASAPD National Championships for physically disabled and visually impaired athletes in April 2019, Coetzee won three gold medals and set a record in the 1 500 m. 

Others from the UFS also honoured

Coetzee has received several awards in her career, but says it is always special to be rewarded by her own federation (FSSAPD). 

Danie Breitenbach (T11) was also honoured as the Senior Male Sports Star. He bagged two gold medals and one silver and set a SA record in both the 800 m and 1 500 m at the nationals. Another Kovsie, Dineo Mokhosoa (F36 – coordination impairments), received a merit award for her gold medal in shot-put and silver in the discus at the national champs.

News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept